Natalia Shcherbakova to Middle Aged
This is a "connection" page, showing publications Natalia Shcherbakova has written about Middle Aged.
Connection Strength
0.153
-
Shcherbakova N, Tereso G, Spain J, Roose RJ. Treatment Persistence Among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder. Ann Pharmacother. 2018 05; 52(5):405-414.
Score: 0.042
-
Shcherbakova N, Rascati K, Brown C, Lawson K, Novak S, Richards KM, Yoder L. Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims. CNS Drugs. 2014 Nov; 28(11):1047-58.
Score: 0.034
-
Shcherbakova N, Shepherd M. Community pharmacists, Internet and social media: an empirical investigation. Res Social Adm Pharm. 2014 Nov-Dec; 10(6):e75-e85.
Score: 0.032
-
Pesaturo K, Shcherbakova N, Mattison M, Greenwald J, Capoccia K. Predictors of HPV vaccine intention in nonmonogamous adults. J Am Pharm Assoc (2003). 2025 Sep-Oct; 65(5):102473.
Score: 0.018
-
Mo Y, Shcherbakova N, Inman KL, Li WK, Kovalenko K, Rosenberg J, Orsini J, Truong J. Evaluation of Individualized Cefepime Dosing Strategy Using Population Pharmacokinetics. J Clin Pharmacol. 2022 03; 62(3):359-365.
Score: 0.014
-
Mo Y, Shcherbakova N, Zeibeq J, Muzykovsky K, Li WK, Gasperino J. Clinical and economic impact of the use of dexmedetomidine for sedation in the intensive care unit compared to propofol. Int J Clin Pharm. 2020 Dec; 42(6):1419-1424.
Score: 0.013